Back to funds

SUPERSTRING CAPITAL MANAGEMENT LP

Updated 6 days ago

Managed by Superstring Capital Management Lp • Latest filing Q3 2026

Portfolio value
$199.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$186.8M
Q1 2026$140M
Q2 2026$158.4M
Q3 2026$199.5M

Top holdings

35 positions as of Q3 2026

View filing
C

COGENT BIOSCIENCES INC

Value
$19.1M
Shares
597.4K
% Port
9.59%
A

AXSOME THERAPEUTICS INC.

Value
$18.9M
Shares
102.5K
% Port
9.47%
T

TREVI THERAPEUTICS INC

Value
$14.1M
Shares
984.9K
% Port
7.07%
G

GENMAB A/S

Value
$13M
Shares
365.7K
% Port
6.54%
?
5.N/A

CLIMB BIO INC

Value
$10.5M
Shares
918.2K
% Port
5.28%
Z

ZAI LAB LTD

Value
$9.6M
Shares
362.7K
% Port
4.79%
A

ADLAI NORTYE GROUP LTD

Value
$9.4M
Shares
588.4K
% Port
4.72%
R

REVOLUTION MEDICINES INC

Value
$8.6M
Shares
41.8K
% Port
4.30%
C

CELLDEX THERAPEUTICS INC NEW

Value
$7.9M
Shares
242.5K
% Port
3.94%
I

IMMUNOVANT INC

Value
$7.5M
Shares
222.1K
% Port
3.76%
U

UROGEN PHARMA LTD

Value
$7.5M
Shares
184.4K
% Port
3.75%
U

UNITED THERAPEUTICS CORP DEL

Value
$7.2M
Shares
13.3K
% Port
3.62%
L

LEGEND BIOTECH CORP

Value
$7.1M
Shares
357.4K
% Port
3.56%
D

DEFINIUM THERAPEUTICS INC

Value
$6.7M
Shares
176.6K
% Port
3.37%
R

ROIVANT SCIENCES LTD

Value
$6.5M
Shares
178.8K
% Port
3.28%
V

VIR BIOTECHNOLOGY INC

Value
$6.5M
Shares
578.7K
% Port
3.24%
I

IONIS PHARMACEUTICALS INC

Value
$5.9M
Shares
132.3K
% Port
2.96%
S

SAVARA INC

Value
$5.3M
Shares
1.02M
% Port
2.63%
S

SAGIMET BIOSCIENCES INC

Value
$4.2M
Shares
423.0K
% Port
2.09%
A

ABIVAX SA

Value
$3M
Shares
30.0K
% Port
1.49%

Explore